“Alzheimer’s disease researchers were buoyed by positive data released Tuesday from a large clinical trial of an experimental therapy being developed by Biogen and Eisai. The early data suggest that the treatment, called lecanemab, eases cognitive decline. The...
“The news: University of Washington spinout AltPep recently raised $44.4 million, according to a regulatory filing. The company declined to discuss the filing, but founder and CEO Valerie Daggett spoke with GeekWire about AltPep’s progress on its experimental...
Review Full Article and Download as a PDF. By Dylan Shea and Valerie Daggett. Biophysica 2022, 2(2), 91-110; https://doi.org/10.3390/biophysica2020010 Received: 7 April 2022 / Revised: 27 April 2022 / Accepted: 27 April 2022 / Published: 28 April 2022...
Join UW Vice Provost for Innovation & CoMotion Director François Baneyx as he speaks with Dr. Valerie Daggett, Founder & CEO of UW spinoff AltPep (https://www.altpep.com/) and professor of bioengineering at the University of Washington, about her...
Recent Comments